- Joined
- Jul 24, 2008
- Messages
- 1,456
- Reaction score
- 3,020
First I did search the forum, couldn't find a recent a thread on this topic, didn't feel like bumping threads from 2022.
In recent months I've been contacted by reps from different companies about the newest latest greatest amniotic/chorionic membrane grafts. The conversations have been light on science and heavy on finance. Apparently these new super-products are extra good, cost $$$ but reimburse $$$$, with profit margins to the tune of $400 per sq cm. I suspect this is a response to the new rules on cellular tissue products, if you can't apply 12 in a row, get the most profit you can applying 4. The graft grift continues on.
What we need is a product that is about the thickness and durometer of plastizote that can be applied to the insole of the shoe and not the wound, and still get reimbursed $$$$. Until then, I hope not to need these new products, but, as the song goes, there ain't no rest for the wicked
In recent months I've been contacted by reps from different companies about the newest latest greatest amniotic/chorionic membrane grafts. The conversations have been light on science and heavy on finance. Apparently these new super-products are extra good, cost $$$ but reimburse $$$$, with profit margins to the tune of $400 per sq cm. I suspect this is a response to the new rules on cellular tissue products, if you can't apply 12 in a row, get the most profit you can applying 4. The graft grift continues on.
What we need is a product that is about the thickness and durometer of plastizote that can be applied to the insole of the shoe and not the wound, and still get reimbursed $$$$. Until then, I hope not to need these new products, but, as the song goes, there ain't no rest for the wicked